Fig. 3
From: Clinical and pathological staging of the cancer at the nanoscale
![Fig. 3](http://media.springernature.com/full/springer-static/image/art%3A10.1007%2Fs12645-012-0028-x/MediaObjects/12645_2012_28_Fig3_HTML.gif)
Conformity of the percent unlabeled fraction of tumor by tritiated thymidine and the malignant fraction in each tumor
From: Clinical and pathological staging of the cancer at the nanoscale
Conformity of the percent unlabeled fraction of tumor by tritiated thymidine and the malignant fraction in each tumor